Therapeutic Approach

Archive: 2010

Ritter Pharmaceuticals, Inc. Awarded a Grant under the U.S. Qualified Therapeutic Discovery Project Program

LOS ANGELES – November 2, 2010 – Ritter Pharmaceuticals, Inc., a biological therapeutics company with a focus on digestive diseases, announced today that it has been awarded a grant by the United States government program, the Qualifying Therapeutic Discovery Project (QTDP).The QTDP grant supports the development of Ritter Pharmaceuticals’ flagship product, RP-G28, as a treatment […]

Leave Your Comments »

Ritter Pharmaceuticals, Inc. wins Top Awards at Venture Capital Investment Competition

Ritter Pharmaceuticals receives the Grand Prize and Audience Favorite awards in the Tech Coast Angels’ Annual Quick Pitch Competition LOS ANGELES – October 11, 2010 – Ritter Pharmaceuticals, Inc., a biological therapeutics company with a focus on digestive diseases, won the grand prize and audience favorite awards in the Tech Coast Angels’ 4th annual Quick […]

Leave Your Comments »

Ritter Pharmaceuticals Wins 2010 San Diego Quick Pitch Competition

CEO Andrew Ritter won the grand prize and audience favorite awards in the Tech Coast Angels’ 4th annual Quick Pitch Competition. The Quick Pitch Competition featured 14 finalists who each gave a brief presentation on their business investment opportunity in front of a panel of industry judges and an audience of over 500 leaders within […]

Leave Your Comments »

Ritter Pharmaceuticals, Inc. Receives FDA IND Approval For Lactose Intolerance Treatment

Ritter Pharmaceuticals, Inc. Receives FDA IND Approval For Lactose Intolerance Treatment LOS ANGELES- June 7, 2010- Ritter Pharmaceuticals, Inc. (Ritter), a pharmaceutical company with a focus on digestive diseases, announced that the United States Food and Drug Administration (FDA) has approved the Company´s Investigational New Drug (IND) application for RP-G28, a novel therapeutic product for […]

Leave Your Comments »

Ritter Pharmaceuticals, Inc. to Discuss Lactose Intolerance and Associated Health Risks at NIH Conference

Ritter Pharmaceuticals, LLC. to discuss lactose intolerance and associated health risks at NIH Conference LOS ANGELES–February 22, 2010–Ritter Pharmaceuticals (www.ritterpharmaceuticals.com), a company dedicated to helping individuals live a healthier and happier life style through improved digestion, announced today that it will join the leading lactose intolerance experts around the country at the NIH Consensus Development […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD